← Evidence map

ArticleTranslational oncology2026

Evaluation of the 1021-HRD assay compared to established HRD testing platforms in ovarian cancer.

Eirini Papadopoulou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 41319389